Epigenetic changes as a common trigger of muscle weakness in congenital myopathies.
about
Malignant hyperthermia: a reviewG9a inhibits MEF2C activity to control sarcomere assembly.NGS Technologies as a Turning Point in Rare Disease Research , Diagnosis and Treatment.Myopathology in congenital myopathies.Cellular, biochemical and molecular changes in muscles from patients with X-linked myotubular myopathy due to MTM1 mutations.Inositol trisphosphate receptor-mediated Ca2+ signalling stimulates mitochondrial function and gene expression in core myopathy patients.
P2860
Epigenetic changes as a common trigger of muscle weakness in congenital myopathies.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Epigenetic changes as a common trigger of muscle weakness in congenital myopathies.
@ast
Epigenetic changes as a common trigger of muscle weakness in congenital myopathies.
@en
type
label
Epigenetic changes as a common trigger of muscle weakness in congenital myopathies.
@ast
Epigenetic changes as a common trigger of muscle weakness in congenital myopathies.
@en
prefLabel
Epigenetic changes as a common trigger of muscle weakness in congenital myopathies.
@ast
Epigenetic changes as a common trigger of muscle weakness in congenital myopathies.
@en
P2093
P2860
P50
P3181
P356
P1476
Epigenetic changes as a common trigger of muscle weakness in congenital myopathies.
@en
P2093
Barbara Mosca
Francesco Zorzato
Haiyan Zhou
Komala Pillay
Luc Heytens
Nicol Voermans
Roberto Gambari
Ruben Attali
Stella Mitrani-Rosenbaum
Susan Treves
P2860
P304
P3181
P356
10.1093/HMG/DDV195
P50
P577
2015-05-27T00:00:00Z